URGN: the cash flow

MyFinsight

For the year ending 2025-12-31, URGN had -$60,968K decrease in cash & cash equivalents over the period. -$162,733K in free cash flow.

Cash Flow	2025-12-31
Net loss	-153,494
Depreciation and amortization	307
Accrued financing on prepaid forward obligation	2,865
Accretion on marketable securities	1,875
Share-based compensation	11,959
Amortization (accretion) of discount on long-term debt	476
Amortization of right-of-use assets	2,104
Acquisitions of ipr&d	3,128
Inventory	7,237
Accounts receivable, net	12,780
Prepaid expenses and other current assets	5,827
Other non-current assets	4,572
Accounts payable and accrued expenses	286
Employee related accrued expenses	2,946
Other current liabilities	-202
Lease liabilities	-639
Restricted deposit	-1
Uncertain tax positions	112
Net cash used in operating activities	-162,444
Purchases of marketable securities	77,400
Maturities of marketable securities	139,247
Purchases of property and equipment	289
Net cash provided by (used in) investing activities	61,558
Principal payments on finance leases	1,855
Proceeds from exercise of options into ordinary shares	1,972
Proceeds from issuance of long-term debt, net of issuance costs	0
Proceeds from pre-funded warrant issuance, net of issuance costs	0
Proceeds from ordinary shares issuances, net of issuance costs	39,801
Net cash provided by financing activities	39,918
Increase (decrease) in cash and cash equivalents	-60,968
Cash, cash equivalents and restricted cash at beginning of year	173,063
Cash, cash equivalents and restricted cash at end of year	112,095

Unit: Thousand (K) dollars (except for numbers of shares and EPS).